5" February, 2016 10 cee The Managor, Listing Department, National Stock Exchange of India Ltd, ‘ SG To, Department of Corporate Services Bombay Stock Exchange Ltd Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai — 400 001, Inge Plaza’, C-1, Block Bandra-Kurla Complex, Bandra (E), Mumbai — 400 051 Ref. : (i) Symbol - DISHMAN Ref.: Scrip Code No. : 532526 (ii) Series ~ EQ At the said Board Meeting the said Unaudited Results were adopted and approved, Which are attached herewith, Wie itv also uploaded the results on the Company's website at vshmanaroup.com and on the website of the stock exchanges at Wwuwbseindia.com ‘and www.nseingia.com, Kindly take this on your record, Thanking you Yours faithfully, For Dishman Pharmaceuticals and Chemicals Limited Tushar D. Shah Company Secretary Encl: As above Dishman Pharmacouticals and Chemicals Limited Registered Office: Bhodr-Ro| Chombers, Swasik Cross Roods, Nevrangpura, Ahmedabad - 380 008 Jn, Tol: +91 (0) 79 26443083 / 26445807 Fox: +91 (0) 79 26420198 Email: dishman@dishmangroup.com Web: www.dishmangroup.com Government Recognised Export House CIN NO 124230611 983LCo0sa29 NSDISHMAN PHARMACEUTICALS AND CHENICALS LIMITED om 242306 J1983P1,C006329 Email D: dlhmandtishmangroup.com Web : www.dlshmangroup.com Bhadr-Raj Chambers, Swastk Cross Roads, Navrangpura, Ahmedabad 380 009 Phone No: 079-26443053 Fax No 08-26420188, Pert: Statement of Standalone / Consolidated Unaudited Results for Quarter and Nine Months Ended 31-12-2015. For Stock Exchange (Rupees in Lacs) ‘STANDALONE. se PARTICULARS For The Guava’ | For The Preceding] ForThe | For Nine Months | For Corresponding | For the Year ended Wo ended ‘Quarerended | Corresponding fended 34-|Nine Months ended] 34-03-2015, se122015 3099-2015 | Quarter ended 122015 st22016 31422014 Unsucited nauaited Unaudited Trawaited ranaied “moat 7 [income From Operations a) Net slesincome fom operators (Net erase ON) TrBBeAE Tae Taso WEB ED Tee [Other Operating meer Tosh OR. Bae 175876 Tia Taree otal income from operations (ne) 2597.98 7028.65 TEI68.08 Teri6a8 EXEC CEE Z [expenses ls) Cost of material consumed eae Foss. S7eTe Tea eae Fea, =) Purchate of sock n-tado 353.10 : 00 359.10 165.14 2588.95, J) Changosin vento of trishod goods, wana Zaz oD) Ta65) 714188 T7863) 226923} Progress and eockintrace a Erpioyes boners expense ae Tests, Tae Ts aaa Sere, fe) Depreciation and emertsaton pee 7108.88 7,089.56, 137.50, 3.328 80 3359.57 441320 I) Omer Ependiure 20167 1587.85 964.02 “54090 5.70878 TAB. rota expenses 373470 304438 2,132.86 25,573.38 3504.45 septe72 3 ]Pront/ (Loss) from Operations belare Other income, 3208.28 "498527 3054 ‘8042.2 7.0670 0408.58 finance costs and exceptional items (12) cz joer: Bae aaa wae 39037 SaoTT, ara ' |Proft/ (Lose) om ordinary aciviies before fiance SHB 3890.58 36aa7e Ta17248 TosTea7 719587 lcosts and exceptional items (3+4) & [Finance cos Ra Tresor 2a. Bo esa Ta, 7 |Proft(Loss) from ordinary actives aftr finance costs 201838 31267 Tas7.18 3.36299 ‘525287 7038259 Jou bore exceptional tams (55) 7 [Becaponat nam Fi 5 Fi : a si ‘9 [Profioss rom Oralnary ACUvies betore tx °8) 7016s SAT Tare SHE ‘SRRLAT TOseR Wo [Tax expense, Tre aes ears Toa, ca TET, 11 Net Pront{Losa) rom Ordinary Actives ator ax (2-70) Ts1t05 “350884 woes 3.39631 73.00.05 ‘e783 7 | Eartnary tome (ok tax enpeneey : = z : 5 5 “3 [Net ProfifLoss) forthe period (11-12) TaTtos oes aa 06ST 300 Seas 7a [income om Rasa : - = ss 5 fron insrest : = > 15 [Net Profit (Loss) afer anos, minorly tareat and TaTOS sees AE E30EaT S00 [share of profit (loss) of associates (1344415)For Stock Exchange 7 [Pais ap Eaay Share Copia Face Value OR Oper oauty share) Tae Tea Tae Taso Tana Tae 78 | RevarvesExcaing Ralualion Reserves as per balance sheet of previous atzcunting year aT 19 | Banc and Dad EPS (ates & air Earnordnary Nema) lorRs. 2 each) I) Basic EPS (Wat annuataeg) 2a To = Tz fy Based EPS (Not annualised) 200 100 738 725 [See accompanying notes to te (ancl TeamsDOISHTAN PHARMACEUTICALS AND CHEMICALS LIED CIN :(242906s1983PLC006329 EmalliD: dishman@dishn ‘ShadrRaj Chambers, Swastik Crose Roads, Navrangpure, AN Partt: Statement of Standalone Consolidated Unauited Res For Stock Exchange (Rupees in Lacs) ‘CONSOLIDATED, Ea PARTICULARS ForThe Guarier[ For The Preceding | Forthe | For Nine Months | For Corresponding | For the Year nded no ‘ended ‘Quartrended | Corresponding landed 34-| Nine Month ended | 31-02-2015, 31122015, 30.08.2015, ‘Quarter ended ‘2206 31122044 31.12.2014 Uravaiiod Taauaiod Unaudited Unaaited Unsuied aoa 7 income From Operations J) Netsatesincome trom oparatons Wel cf Ose Gay Tea TSE WEBS] — TEED TSarEer TES Othe Operating some ee7 Tae er es TAT, a7 Total income from operations (net) E873 90 Tene Sisea.te | tiv.305.83 Tis 16225 WeasTa76 2 Expenses. a) Cost of aioe conse 7am ae Taso DT CPE eee, ) Purchase of sociin trade i - Oa : 163.14 2506.68, [2 Changes in inventories of shod ponds, won waar ae Tae 05} Toma T7680 4.25800) Jrogress and sockintrace | Eneloyes tenotis pence aon I Tao wa ee CR ) Depretaten and amortsaton OSTaS 270073 251225 25626 71616 3.00887 BOTA Ip Other Expendtire 42042 7.51021 748.30 72.958.66 BsT4 23 30 396.47, [rota expenses 30.5862 3157006 3472280 34,736.10, 79:303.06, qansrazt ' |Proft/ (Los) from Operations before Other come, 8200.76 650837 “aaa BESTS 15,008.40 16,198.54 finance costs and exceptional toms (1-2) [omer come ae Tease Tis TSS Tsar Sea, ' [Profit (Loss) rom ordinary actives before nance was608 Ta88 73 562430 7416.58 Tres 74,650.89 lcosts and exceptional ems (+4) & [Finance costs Taso eam eer Tee SaTEDT arOee 7 [Prof(toss) rom ordinary acvlles ator fnance costs “30624 “4909.27 3086.14 76.61079 Toseat2 7591055, but tore exceptional tems (-6) [Exceptional ame z 7 - 5 ‘9 |Profiv(Loss ron Ordinary Activites bofore tax 7-8) a6 sana ay TERS Tae Tests To [fax expense, Taare PEI) eae 80057 2a saa 1 Net Profl(Loss) rom Ordinary Active afer x [E7H) “405006 3850.24) 2a05at 11942 ‘165 TH aT6o8 12 | Exvaordnay terre (et of ax pense) zi 7 q = 13 [Net Profiu(Loss) or the period (1-72) aaa Tae Fat area BERS TraTeae 7a income om Assocs Fi 5 al oie. 3a as 745 [Mino rire 2 + i a 16 [Net Profit (Loss) afar taxes, minority ierest and Ta, See A033 EADS wana Tse [share ot profit (loss) of associates (3+ 14r15),For Stock Exchange 1 [Fackap ty Shave Capi (ace Vales TRS O-PS fouiy shar) Tas Tease Taso Tas Taise Tass “8 | Reserves Excicing Revaluation ReBewes 65 per DANCE rect of previous accountng year TET ‘9 [Basic and ORES EPS [Wale & ater ExraorSay Tama] ors. 2eacny [p Basic EPS (WoL anmualaog) a a Zoe Tae Tae fi Dived EPS (Not annuated) a2 452 1.08 Tee See accompanying notes othe inant ToaRaFor Stock Exchange Segment wise Revenue, Result and Captal Employed sr PARTICULARS For The Guartor For The | For ine Months | For Coreaponding | For th Voar ended No ended Corresponding fended 31 Nine Months ended | 31-08-2016 31122016 30082018 ‘Quarter ended 122015 ‘Sttza0i4 3122014 Travcited Unaacited Urauaiiod Ursus Taaied 7 [Segment Revenue fer craus: Reser Bais Hae Tee TESTS [o) Omers 0,399.73 944027 3410074 S773 47,005.23 Feta 37,368.45 Beste] iso Tsrze7 7s5.094398 Less: ntor-sogmant Revenue” : : a [Net Sales ncome from Operation wiateas eas | ese Tawa Tea 2 [Segment Rests (Praft.oes) bore ak and THGTSST from each segment} fe craws® Sea aT FET TEATRO TRI BREE fo otnere™ Tees Tar sie BES 20167 Zoe rota 35307 aaa Bars Te a080 Teas ess: Dinero 2.35006 208022 730879 47201 ‘aa706s [9 tier un etocabieexpenare nat a a aocabe (76036) 070.13] 71368. Tish 29] 76.686.) [Total Proft(Losa) Before Tar aaa SSE Ese TORTS TTA 5 [Pept Employed (Segment Assets Segment TaiAioay [a CRANES. Toasoase Taree Tos 72005 |e OETA ToeaTAOs He) Others 96.264.69 8,003.91 82,507.25, 195,284.60 (82,507.25 4,531.57 lo Unatocabie 2287.18 25,085 88 25,653.57 aD 25595 67 5241.99 [otal 223.460.19 BHAT 96 219,800.80] ——223.460-18 213,860.56 Zire % Inoudes Forex (Coss) Gain For ang on behalf ofthe Board Place: Ahmedabad loate 6h February, 2016Notes: 1. _The Financial results have been reviewed by the Audit Committee and taken on record by the Board of Directors at their ‘heetings held on 5" February, 2016 2 Joint Statutory Auaitors have caried out a “Limited review’ ofthe standalone financial result of the Company for the quarter ended 31* December, 2015, es have been re-grouped, re-cast and re-arranged wherever considered necessary; 4 As per Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, the Company has opted to Publish only consolidated financial results. The stand-alone financial results are available for perusal on the Company's ‘website as well as on the stock exchanges’ websites as stated below: woww.dishmanaroup com, ywww.bseindia.com, and wow.nseindia.com. 5. ~As per Accounting Standard (AS) 17 - “Segment Reporting’, segment information has been provided in Consolidated Financial Result, 6. The business segments of the Company comprise the followings: ‘Segment Description of the activity _ ‘CRAMS. Contract Research and Manufacturing Segment under Tong term supply = ‘agreements [OTHERS Bulk Drugs, intermediates, Quats, Specialy Chemicals and Traded Goods 7. Consolidated francial results comprise the results ofthe parent Company, Dishman Pharmaceuticals and Chemicals Limited Bsus, subsidiaries viz. Dishman Europe Limited, Dishman USA Ine., Dishman Intemational Trading (Ghanghay Gor Lice Prana Sultzeriand Limited, Dishman Pharma Solutions AG, Switzerland, CARBOGEN AMCIS (Shanghai) Gor Lid formes frown 2s Dishman Pharmaceuticals & Chemicals (Shanghal) Co. Lid, Shanghai Yigian Intemational Trade Gen Lia Grovative. Ozone Services inc. (1038), Dishman Netherlands B. V. (formerly known as “Pharma Syn 8. V.), Cohecis Fing Carmona a lormerty known as ‘Dishman Holland B.V.), Carbogen Amcis Ltd (formerly known as “Synproiec DR Lid.) GARBOGEN AMCIS.AG, Switzerland, Carbogen Ames (india) Limited, Dishman Australasia Ply. Lid. Dishman Gate Lia SARBOGEN AMCIS SAS, Dishman Middle East (FZE), Dishman Japan Limited, one joint venture Company, namely Schuts pishman Biotech Ltd (22.33% holding by Dishman), and one associate company namely, Bhadr-Rej Holdings Pvt Lid, (40% holding by Dishman) as per relevant Accounting Standards. 8. Pursuant to Regulation 47 of SEBI (Listing Obligalions and Disclosure Requirements) Regulation 2016, the aforesaid financial Result may be accessed on the Company's website at www.dishmangroup.com and may also be accessed at the website of the Stock Exchanges where the shares of the Company are listed at \www.bseindia.com and www.nseindia.com. — : On behalf of the Board of Directors Managing Director & CFO@dishman To, Department of Corporate Services Bombay Stock Exchange Ltd. Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai - 400 001 5” February, 2016 To, The Manager, Listing Department, National Stock Exchange of India Ltd, “Exchange Plaza”, C-1, Block G, Bandra-Kurla Complex, Bandra (E), Mumbai - 400 051, Ref.: (I) Symbol - DISHMAN (il) Series - EQ Ref.: Scrip Code No. Sub.: Submission of Statutory Auditors’ d Review Report - Regulation 33 Dear Sir, As per the requirement of Regulation 33 SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we submit herewith a copy of Statutory Auditors’ Limited Review Report dated 5" February, 2016 signed by Ws. V. D. Shukla & Co, and Ms. Haribhakti & Co. LLP, Chartered Accountants, Joint Statutory Auditors of the ‘Company in respect of the Unaudited Financial Results of the Company for the quarter ended 31 December, 2016. ‘We would like to inform you that the above referred Limited Review Report was placed before the Board. Kindly take the same on your record and oblige. Thanking you, Yours faithfully, For Dishman Pharmaceuticals and Chemicals Limited Ge. Tushar D, Shah Company Secretary Encl.: As above Dishman Pharmaceuticals and Chemicals Limited Registered Office: Bhodr-Roj Chambers, Swostk Cross Roads, Navrangpure, Ahmedabad ~ 380 009 Indi. Tel: +91 (0) 79 26443053 / 26445807 Fox: +91 (0) 79 26420198 S Email: dishman@dishmangroup.com Web: www.dishmangroup.com Government Recognised Export House. CIN NO 1242306s1989PLC006329Limited Review Report Review Report to The Board of Directors Dishman Pharmaceuticals and Chemicals Limited 1. We have reviewed the accompanying Statement of Unaudited Financial Results of Dishman Pharmaceuticals and Chemicals Limited (‘the Company’) for the Quarter ended December 31, 2015 ("the Statement”). This Statement is the responsibility of the Company's Management and has been approved by the Board of Directors. Our responsibility is to issue a report on the Statement based on our review. 2. We conducted our review in accordance with the Standard on Review Engagement (SRE) 2410, “Review of Interim Financial Information Performed by the Independent Auditor of the Entity” 'ssued by the Institute of Chartered Accountants of India. This standard requires that we plan and perform the review to obtain moderate assurance as to whether the Statement free of material misstatement. A review is limited primarily to inquiries of Company personnel and analytical procedures applied to financial data and thus provide less assurance than an audit. We have not performed an audit and accordingly, we do not express an audit opinion,3. Based on our review conducted as above, nothing has come to our attention that causes us to Believe that the accompanying Statement, prepared in accordance with applicable accounting Standards as specified under Section 133 of the Companies Act, 2013 read with Rule 7 of the Companies (Account) Rules, 2014 and other recognised accounting practices and policies has not disclosed the information required to be disclosed in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, including the manner in which it is to be disclosed, or that it contains any material misstatement. For Haribhakti & Co. LLP For V. D. Shukla & Co. Chartered Accountants Chartered Accountants ICAI Firm Registration No.103523W ICAI Firm Registration No. 110240W “Bartar Mite as Bhavik L. Shah Vimal D. Shukla Partner Proprietor Membership No. 122071 Membership No. 036416 Place: Ahmedabad Date: February 05, 2016DISHMAN PHARIEACEUTICALS AND CHEMICALS LIMITED (Ge: (282306.19830LC006%29 Ema ID: dshman®dlshimangroup.com Wb: wiw.cishmangroup.com ‘hac Ro] Chamber, Swastk Gross Ross, Marangpur, Abmodabad80000Phane No 70t044000 Pox No: OT2:26420186: Patt: Statement of Standslone UnaudedResul for Quran Nine Monthe Enea st este (Rupees nts) SNORE Forte | Forte Ls Foethe Fortine | comssponding| Forte Yeor a ann arcrenans| Presta | coneapenang | Pot MMe, aresront t= uns Saiszao’ | xara} Guar ead [Mies Mine ots | ned seasanis. | ottzanne ae raed |“ Unnaed |“ Uneuaied | Unaaaieg | tracted | Ra eyReteisincene Fon cwalona Neto | —TTREA2] —aTREBe| —TERESa]} —sasea7o] —arraase} ar lee amy fs) oer Opaatig reas aatse| ar Sai | rare] — see] a [ott nome rom opratans A esa7s6| Foes. s3| Tz ish09| se rine | —searcas | — aes lj cost of aa cae OaEIO| “aoe 6| “sree | mero | — eas] ae [Purchase of sk ace Sexo : a9] sa. rease[ ase [ogee hire ‘ose | eas ay) aaa] Tat at] — 0838] — en) [a Eraigjee Donors ae Tas | rrr] — rey SEE -) Deeds and anceston Sais 7.i0sas | 16086] 170 amaze ober epee ‘biker | teres | —— Tae 731 otal expenses srsaro| — gona | —a anes Eun 7 JPrott Lose) ran Opinions Detar Other | anes | -—tsesat] asa oaDks Income, tance costs and exceptional tomo ley 7 onernane Ba] ase | — amar | ara} ar [eet (Loss) Wom rina eave bofora]|——Taaastz|_—gaane | ance | aa trzan| Tere? |} tesa nance cost and exceptional teme (et), Coo ROE | peer | aso | ares |] — are | a 7 roicoss) om oan avi er z01039| —s,isaer} irae] —asuaso] —— sear] tas fnance coats bt befor exceptional Kom fee 7 porate - 2 [ross ro OTS RET ae Saar ——aasite| —anezaa} sana] fc) 7 ex expanae rE| Te ae] eae] ae] ae 7 Pet Prottose) om Ordinary Raos Tatts] 39085 wakas | —eatest | ——azenas | — saunas oi), 72 | Eavorinay tore GALT T CRT 7 zi - - 73 at PretatLser er Taos] ae a 7 [as os Rano 5 Fi Fi 7 ay rt. I = = 7 filet rot (one Sar ae, wna Tania] — aaa areas a terest nd share of rot os) of lesson (301409 JP Egy Share Coal Fas Vabn et TSBs] Tae] TREE} TES] TS] ls 2 por at rae) "i [Resaves cg Reva RSENS 5 : 5 EvETT pe balance set of previous acai your [base and DaSTEMS ele wor 5 Fi 5 i i lessor toms) (of sey [Sasi |F 5 Not stead 2 TH cy 7 30 Tz Load EPS (Not arruaiod) 200 ao 100 Tas 230 73 [Se axoriparyng nts fe areal Tare Pics: Anmedated [Dste: tn February. 2006Notes: Place: Ahmedabad Dat ‘meetings held on 5" February, 2016 ~oint Statutory Auditors have caried out a“Linited review’ of the standalone financial result of the Company for the quarter ended 31" December, 2015 ‘The figures have been re-grouped, re-cast and re-arranged wherever considered necessary; As per Reguiation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2016, the Company has opted to publish only consolidated financial resuls. The stand-alone financial results are availtle tar perusal on the Company's ‘website as well as on the stock exchanges’ websites as stated below. sewn cishmangroup.com, www bseindia.com, and www.nseindia.com, ‘As Per Accounting Standard (AS) 17 - “Segment Reporting’, segment information has been Provided in Consolidated Financial Result. Fussiant to Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015, the aforesaid financial He atone accessed on the Company's website at waw.dishmangroup.com and thay as Ce ‘accessed at the website of the Stock Exchanges where the shares of the Company are listed al wawv-bselndia,com anc amye ecco com. February, 2016